trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Hou X et al. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma. 2016 Clin Respir J pmid:25307458
Vilar E et al. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. 2009 Clin. Cancer Res. pmid:19351759
Deng G et al. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. 2009 Clin. Cancer Res. pmid:19223499
Hirata H et al. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. 2009 Clin. Cancer Res. pmid:19755393
Marchion DC et al. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. 2005 Clin. Cancer Res. pmid:16322310
Obata T et al. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. 2003 Clin. Cancer Res. pmid:14695142
Heller G et al. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. 2012 Clin. Cancer Res. pmid:22282464
Gagnon JF et al. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. 2006 Clin. Cancer Res. pmid:16551870
Vigushin DM et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. 2001 Clin. Cancer Res. pmid:11309348
Lin KT et al. HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy. 2012 Clin. Cancer Res. pmid:22811583
Woodfield GW et al. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. 2009 Clin. Cancer Res. pmid:19458056
Hauswald S et al. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. 2009 Clin. Cancer Res. pmid:19458058
Toyooka S et al. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. 2002 Clin. Cancer Res. pmid:12114433
Fang MZ et al. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. 2005 Clin. Cancer Res. pmid:16203797
Chang TH and Szabo E Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. 2002 Clin. Cancer Res. pmid:11948134
Thiel A et al. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. 2009 Clin. Cancer Res. pmid:19584167
Landreville S et al. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. 2012 Clin. Cancer Res. pmid:22038994
Takai N et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. 2004 Clin. Cancer Res. pmid:14871994
Banwell CM et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. 2006 Clin. Cancer Res. pmid:16609009
Touma SE et al. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. 2005 Clin. Cancer Res. pmid:15867260
Dalgard CL et al. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. 2008 Clin. Cancer Res. pmid:18483379
Egler V et al. Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death. 2008 Clin. Cancer Res. pmid:18483381
Sato N et al. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. 2005 Clin. Cancer Res. pmid:16000561
Munshi A et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. 2005 Clin. Cancer Res. pmid:16000590
Rüller S et al. Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: a new therapeutic strategy. 1999 Clin. Cancer Res. pmid:10537334
Tang XX et al. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. 2004 Clin. Cancer Res. pmid:15355914
Singh AK et al. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer. 2015 Clin. Cancer Res. pmid:26130461
Alao JP et al. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. 2004 Clin. Cancer Res. pmid:15585645
Iljin K et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. 2009 Clin. Cancer Res. pmid:19789329
Kim IA et al. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53. 2006 Clin. Cancer Res. pmid:16467109
Gonçalves J et al. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. 2005 Clin. Chem. Lab. Med. pmid:15843208
Doñas C et al. Trichostatin A promotes the generation and suppressive functions of regulatory T cells. 2013 Clin. Dev. Immunol. pmid:23737814
Choi JH et al. Trichostatin A attenuates airway inflammation in mouse asthma model. 2005 Clin. Exp. Allergy pmid:15649272
Cho JS et al. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. 2012 Clin. Exp. Allergy pmid:22239687
Tsaprouni LG et al. Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation. 2007 Clin. Exp. Immunol. pmid:17711487
Malago JJ et al. Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells. 2005 Clin. Exp. Immunol. pmid:15958071
Guo W et al. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. 2015 Clin. Exp. Metastasis pmid:25579665
Huang X et al. Nitric oxide (NO), methylation and TIMP-1 expression in BL6 melanoma cells transfected with MHC class I genes. 2000 Clin. Exp. Metastasis pmid:11448064
Osborn NK et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. 2006 Clin. Gastroenterol. Hepatol. pmid:16469682
Sterthaus O et al. Evaluation of in vitro cultured rat oocytes, from different strains, by spindle morphology and maturation-promoting-factor activity combined with nuclear-transfer experiments. 2009 Cloning Stem Cells pmid:19751114
Beebe LF et al. Cytochalasin B and trichostatin a treatment postactivation improves in vitro development of porcine somatic cell nuclear transfer embryos. 2009 Cloning Stem Cells pmid:19780698
Mizumoto S et al. The developmental potential of parthenogenetic and somatic cell nuclear-transferred rat oocytes in vitro. 2008 Cloning Stem Cells pmid:19049415
Li X et al. The effects of trichostatin A on mRNA expression of chromatin structure-, DNA methylation-, and development-related genes in cloned mouse blastocysts. 2008 Cloning Stem Cells pmid:18241125
Baqir S and Smith LC Inhibitors of histone deacetylases and DNA methyltransferases alter imprinted gene regulation in embryonic stem cells. 2006 Cloning Stem Cells pmid:17009896
Zhang Y et al. An epigenetic modifier results in improved in vitro blastocyst production after somatic cell nuclear transfer. 2007 Cloning Stem Cells pmid:17907946
Iager AE et al. Trichostatin A improves histone acetylation in bovine somatic cell nuclear transfer early embryos. 2008 Cloning Stem Cells pmid:18419249
Meng Q et al. Live birth of somatic cell-cloned rabbits following trichostatin A treatment and cotransfer of parthenogenetic embryos. 2009 Cloning Stem Cells pmid:19196041
Yuan TF et al. The epigenetics changes in Parkinson's disease: a novel therapeutic target. 2014 CNS Neurosci Ther pmid:24629108
Zhu M et al. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. 2014 CNS Neurosci Ther pmid:24351065
Giles KE et al. Chromatin boundaries, insulators, and long-range interactions in the nucleus. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21047907
Eskeland R et al. Histone acetylation and the maintenance of chromatin compaction by Polycomb repressive complexes. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21502416
Igaz N et al. Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles. 2016 Colloids Surf B Biointerfaces pmid:27434153
Yagi K et al. Histone Deacetylase Inhibition Protects Mice Against Lethal Postinfluenza Pneumococcal Infection. 2016 Crit. Care Med. pmid:27352127
Das ZC et al. Lyophilized somatic cells direct embryonic development after whole cell intracytoplasmic injection into pig oocytes. 2010 Cryobiology pmid:20691649
Yang W et al. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. 2014 Curr Alzheimer Res pmid:25387339
Bonetto A et al. Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. 2009 Curr Cancer Drug Targets pmid:19508174
Blanquart C et al. Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds. 2011 Curr Cancer Drug Targets pmid:21762083
Nielsen J Combinatorial synthesis of natural products. 2002 Curr Opin Chem Biol pmid:12023109
McBlane F and Boyes J Stimulation of V(D)J recombination by histone acetylation. 2000 Curr. Biol. pmid:10801420
Sommer A et al. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. 1997 Curr. Biol. pmid:9197243
Chiocca S et al. Histone deacetylase 1 inactivation by an adenovirus early gene product. 2002 Curr. Biol. pmid:11937030
Olsson TG et al. Transient inhibition of histone deacetylase activity overcomes silencing in the mating-type region in fission yeast. 1999 Curr. Genet. pmid:10079326
Lin S et al. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. 2011 Curr. HIV Res. pmid:21631428
Vanhaecke T et al. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. 2004 Curr. Med. Chem. pmid:15180568
Jung M Inhibitors of histone deacetylase as new anticancer agents. 2001 Curr. Med. Chem. pmid:11562279
Lee J et al. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS). 2014 Curr. Med. Chem. pmid:25005187
Iancu-Rubin C and Hoffman R Role of epigenetic reprogramming in hematopoietic stem cell function. 2015 Curr. Opin. Hematol. pmid:26049747
Adcock IM et al. Epigenetic regulation of airway inflammation. 2007 Curr. Opin. Immunol. pmid:17720468
Xu S et al. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells. 2014 Curr. Pharm. Des. pmid:23888960
Huang N et al. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. 1997 Cytokine pmid:9067093
Gray SG et al. IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a. 2000 Cytokine pmid:10880258
Wang S et al. Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer. 2016 Cytokine pmid:27500645
Zhao XY et al. Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. 2005 Cytokine pmid:15996479
El-Khoury V et al. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells. 2004 Cytometry A pmid:15517561
Zhao H et al. New biomarkers probing depth of cell senescence assessed by laser scanning cytometry. 2010 Cytometry A pmid:20939035
Golfier S et al. High-throughput cell mechanical phenotyping for label-free titration assays of cytoskeletal modifications. 2017 Cytoskeleton (Hoboken) pmid:28445605
Rolando M et al. Contractile actin cables induced by Bacillus anthracis lethal toxin depend on the histone acetylation machinery. 2015 Cytoskeleton (Hoboken) pmid:26403219
Young JC et al. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. 2004 Cytotherapy pmid:16146885
Drela K et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. 2014 Cytotherapy pmid:24726658
Obier N et al. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival. 2010 Cytotherapy pmid:20210674
Kishigami S et al. Epigenetic abnormalities of the mouse paternal zygotic genome associated with microinsemination of round spermatids. 2006 Dev. Biol. pmid:16325170
Almouzni G et al. Histone acetylation influences both gene expression and development of Xenopus laevis. 1994 Dev. Biol. pmid:7958429
De La Fuente R et al. Major chromatin remodeling in the germinal vesicle (GV) of mammalian oocytes is dispensable for global transcriptional silencing but required for centromeric heterochromatin function. 2004 Dev. Biol. pmid:15501230
Shen YC et al. The cytokine macrophage migration inhibitory factor (MIF) acts as a neurotrophin in the developing inner ear of the zebrafish, Danio rerio. 2012 Dev. Biol. pmid:22210003
Ma P and Schultz RM Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. 2008 Dev. Biol. pmid:18501342
Maatouk DM and Resnick JL Continuing primordial germ cell differentiation in the mouse embryo is a cell-intrinsic program sensitive to DNA methylation. 2003 Dev. Biol. pmid:12781693
De La Fuente R et al. ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. 2004 Dev. Biol. pmid:15242786
Iezzi S et al. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. 2004 Dev. Cell pmid:15130492
Fujita Y et al. Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. 2007 Dev. Cell pmid:17199038
Sachs LM et al. Involvement of histone deacetylase at two distinct steps in gene regulation during intestinal development in Xenopus laevis. 2001 Dev. Dyn. pmid:11668605
Shah RR et al. Regulation of primitive hematopoiesis by class I histone deacetylases. 2013 Dev. Dyn. pmid:23184530
Xu RH et al. Histone acetylation is a checkpoint in FGF-stimulated mesoderm induction. 2000 Dev. Dyn. pmid:10906781
Shi LH et al. Trichostatin A (TSA) improves the development of rabbit-rabbit intraspecies cloned embryos, but not rabbit-human interspecies cloned embryos. 2008 Dev. Dyn. pmid:18265023
Keil KP et al. Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein-dependent mechanism. 2015 Dev. Dyn. pmid:26283270
Michalak P Evidence for maternal imprinting of 45S ribosomal RNA genes in Xenopus hybrids. 2014 Dev. Genes Evol. pmid:24477594
Nemer M Histone deacetylase mRNA temporally and spatially regulated in its expression in sea urchin embryos. 1998 Dev. Growth Differ. pmid:9865968
Iwashita J et al. Histone deacetylase induces accelerated maturation in Xenopus laevis oocytes. 2013 Dev. Growth Differ. pmid:23346879
Worrad DM et al. Temporally restricted spatial localization of acetylated isoforms of histone H4 and RNA polymerase II in the 2-cell mouse embryo. 1995 Development pmid:7555721
Svensson K et al. The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. 1998 Development pmid:9389664
Yeh JR et al. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. 2008 Development pmid:18156164